ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

9,685Medicare Part D Prescriptions Filled, Including Refills
$765K Total Retail Price of All Prescriptions
433 Patients Receiving at Least One Drug in Part D
22%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
TRAZODONE HCL 633 118
ZOLPIDEM TARTRATE 382 99
BENZTROPINE MESYLATE 373 12 R
SERTRALINE HCL 321 68
MIRTAZAPINE 228 81
CITALOPRAM HBR 228 93
QUETIAPINE FUMARATE 221 20
PERPHENAZINE 220 37
CYMBALTA 213 48
RISPERIDONE 185 20
AMITRIPTYLINE HCL 166 24 R
LITHIUM CARBONATE 166 0
LOXAPINE 155 0
LAMOTRIGINE 153 0
BUSPIRONE HCL 153 11
BUPROPION HCL SR 147 14
OLANZAPINE 130 18
ESCITALOPRAM OXALATE 129 32
ZIPRASIDONE HCL 126 24
AMLODIPINE BESYLATE 125 71
ABILIFY 113 0
DOXEPIN HCL 110 0
VENLAFAXINE HCL ER 108 20
LEVOTHYROXINE SODIUM 106 56
OMEPRAZOLE 101 40
PAROXETINE HCL 101 0
FLUOXETINE HCL 92 0
HYDROXYZINE PAMOATE 90 0 R
DIVALPROEX SODIUM ER 83 0
DONEPEZIL HCL 81 42
PRISTIQ ER 74 11
GABAPENTIN 72 25
LATUDA 70 0
SEROQUEL 68 0
RANITIDINE HCL 68 39
ATORVASTATIN CALCIUM 67 39
ACETAMINOPHEN-CODEINE 66 26 S3
BUPROPION XL 64 0
LOSARTAN POTASSIUM 63 35
LISINOPRIL 63 24
FUROSEMIDE 62 34
METFORMIN HCL 59 16
PROAIR HFA 59 25
HALOPERIDOL 58 0
DIVALPROEX SODIUM 56 0
PROPRANOLOL HCL 56 0
CARBAMAZEPINE 54 0
GLIMEPIRIDE 53 29
ZYPREXA 53 0
GENERLAC 51 0
PRAVASTATIN SODIUM 50 0
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.